The U.S. Department of Agriculture has reportedly been asked by a Canadian
biotechnology company to approve its genetically modified (GM) apple,
which resists browning after it is sliced. The British Columbia-based company
apparently licensed the non-browning technology from an Australian
company that developed it for potatoes. Approval of the GM technology
could take several years, and U.S. apple growers have reportedly expressed
concerns about cross-pollination with conventional apple trees as well as the
cost of replanting apple groves with the “Arctic” apples, a figure estimated at
$10,000 to $20,000 per acre.

Andrew Kimbrell, executive director of the Center for Food Safety, criticized the proposal, apparently claiming, “A botox apple is not what people are
looking for. I’m predicting failure.” Yet, the sliced apple market has increased in
recent years, with suppliers relying on calcium and ascorbic acid to maintain
product freshness. The company seeking the GM apple’s approval claims that
the technology will reduce the cost of producing fresh slices. While reluctant
to adopt any new technology that could turn off consumers on the basis of
taste or preference, the U.S. apple industry is apparently interested in learning
more about the product. See Associated Press, November 30, 2010.

About The Author

For decades, manufacturers, distributors and retailers at every link in the food chain have come to Shook, Hardy & Bacon to partner with a legal team that understands the issues they face in today's evolving food production industry. Shook attorneys work with some of the world's largest food, beverage and agribusiness companies to establish preventative measures, conduct internal audits, develop public relations strategies, and advance tort reform initiatives.

Close